FDG-PET in early AD diagnosis.
Where this comes from
- Record sourced from PubMed, PMID 23642583.
- Also identified by DOI 10.1016/j.mcna.2012.12.016.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
FDG-PET is a valuable tool that will continue to aid in identifying AD in its prodromal and early dementia stages, distinguishing it from other causes of dementia, and tracking progression of the disease. As brain FDG-PET scans and well-trained readers of these scans are becoming more widely available to clinicians who are becoming more informed about the role FDG-PET can play in early AD diagnosis, its use is expected to increase.
Medical subject headings
- Alzheimer Disease
- Asymptomatic Diseases
- Brain
- Early Diagnosis
- Fluorodeoxyglucose F18
- Positron-Emission Tomography